Tuesday, July 17, 2007
CyberKnife Eliminates Tumors and Lesions
CyberKnife Treatment Center Uses Revolutionary Methods to Completely Eliminate Tumors and Lesions in a Nonsurgical Manner. Dr. Schwadenternationally a recognized expert in the field of radiosurgery creates Centers in Mimai & West Palm Beach Florida.
Miami, FL (PRWEB) July 10, 2007 -- MORSE LLC - which operates The CyberKnife Centers of Miami and Palm Beach have taken measures to make pertinent life-saving information, more accessible for cancer patients, their families, or other individuals who wish to become knowledgeable about radiosurgery by launching a new website, http://www.morsecyberknife.com Specifically for individuals who suffer from conditions that require radiation treatment or therapy, the website features sections for doctors and patients as well as an interactive feature to help pinpoint where the user's specific problem may be in their individual body. Contact information for highly experienced and trained staff, physicians and surgeons in the South Florida region is also available.
CyberKnife is a highly advanced radiation tool that facilitates the administration of radiation to parts of the body that are deemed inoperable with more conventional treatment methods. These areas include, but are not limited to, parts of the brain, internal organs, and spinal cord. Using this revolutionary method, tumors and lesions can be completely eliminated in a nonsurgical procedure with three to five treatments and virtually no side effects.
With the CyberKnife:
No incisions are made
No anesthesia is required
There is no blood or pain
There is no recovery time needed after the procedure.
"We treat brain, spine, lung, pancreas, liver, prostate, head and neck, and other conditions throughout the body where radiation treatment is indicated. Many of our patients are treated with the CyberKnife for conditions that have been deemed inoperable, or for areas that have previously received the maximum level of radiation," says Executive Director James G. Schwade, MD, FACR, FACRO. "The range, accuracy and precision of the CyberKnife system can help target areas that may not be suitable for treatments with traditional surgery, radiation therapy, or older radiosurgery systems like the gamma knife."
The procedure is performed with a team of experienced physicians and can cost 20% to 45% less than traditional radiosurgery treatments. Conditions treated with the CyberKnife include various cancers, tumors, functional disorders, and lesions throughout various parts of the body. Over 10,000 patients worldwide have been treated using this system, and many operations have proven successful for patients previously told that their tumors were inoperable with traditional forms of radiation therapy.
About The CyberKnife Center of Miami/Palm Beach Online
The CyberKnife Center of Miami is dedicated to providing world class treatment and support for eligible candidates who may have lost hope for recovery with prior procedures. By visiting the CyberKnife Center of Miami /Palm Beach online, individuals are able to review information regarding treatments and procedures. The new website features detailed information about candidate eligibility for this type of radiosurgery, conditions treated, individual case studies, cybernotes, and more. Visitors are able to contact the center via the website with questions about radiosurgery or the team of medical professionals administering treatments.
James G. Schwade, MD, FACR, FACRO
Dr. Schwade is an internationally recognized expert in the field of radiosurgery who has performed over 1,700 treatments and authored over 80 scientific articles in the span of his 20 year career. A member of numerous state and national professional societies, he currently holds the rank of Clinical Professor of Radiation Oncology at the University of Miami School of Medicine. A cum laude graduate of both Washington University and the Medical College of Wisconsin, Dr. Schwade has served as Co-Medical Director at the Miami NeuroScience Center, Associate Director of Clinical Research at the University of Miami Sylvester Comprehensive Center, Medical Director of the Regional Cancer Treatment Center at Baptist Hospital in Miami, and Chief of the Radiology Biology Section of the Radiation Oncology Branch at the National Cancer Institute in Bethesda, Maryland.
Xiadong Wu, PhD
Dr. Wu is Associate Professor and Chief of the Medical Physics Division in the Department of Radiation Oncology at the University of Miami School of Medicine.
He graduated from the University of Miami with a Ph.D. in Biomedical Engineering and has an undergraduate degree in Physics from Xiamen University in the People's Republic of China. Dr. Wu is certified by the American Board of Radiology in Therapeutic Physics and in 2000 received a U.S. patent for Iso-Energetic Intensity Modulator for Therapeutic Electron Beams. He is a frequent lecturer on medical physics throughout the United States and has authored and co-authored numerous monographs, peer-reviewed journals and abstracts.
Steven Pinkert, MD, JD, MBA
As a key member of the management team, Dr. Pinkert provides corporate, regulatory and intellectual property services invaluable to the success of the company. He graduated cum laude from the University of Southern California, and holds a medical degree from Northwestern University Medical School, a Juris Doctor degree from the University of Miami School of Law, and a Master in Business Administration from the University of Miami Graduate School of Business Administration. A member of the American Medical Association, American Bar Association, the American Trial Lawyers Association, his experience and exceptional background in Medicine, Law and Business play a vital role in the development and operations of the CyberKnife Center of Miami.
The MorseCyberKnife.com Web site is developed by a leading Maimi | West Palm Beach Web Design Company // Forte Interactive.
Press Contact: James G. Schwade, MD, FACR, FACRO
Company Name: MORSE LLC
Friday, July 13, 2007
Mesothelioma Portal Work Continues
Far from being a fading issue, mesothelioma related to asbestos exposure is an ongoing problem, particularly for disaster relief workers who may have been exposed during Hurricane Katrina and September 11th cleanup efforts. LegalView.com is proud to keep its readers updated with the latest news and science on mesothelioma, asbestosis and other asbestos-related diseases.
Denver, CO (PRWEB) July 13, 2007 -- Your resource on the web for legal issues that affect contemporary America, LegalView.com, is pleased to continue bringing readers up-to-date on the news, research and legal developments about mesothelioma. Mesothelioma is a rare and severe type of lung cancer that is almost always caused by exposure to asbestos, a once-popular building material that doctors now know is a carcinogen. Visitors to LegalView.com's mesothelioma lawyer portal may browse continually-updated news feeds, original articles, encyclopedia entries, a glossary of mesothelioma-related terms and an Asbestos & Mesothelioma blog, where users can read and comment on the latest news related to these important topics.
Thousands of Americans, mostly men, were exposed to asbestos through their jobs in the first half of the 20th century, when the material was widely mined and used in building insulation, shipyards, brake pads and other industrial applications. Decades later, many of these workers discovered too late that their work with asbestos led to developing mesothelioma, a crippling type of lung cancer that attacks the lining of the lung. Others may have been exposed more recently, due to illegal and unsafe practices at modern work sites, disaster relief work near buildings that contain asbestos, or work in the few industries that still use asbestos, despite decades of evidence that it causes serious cancers. Unlike most lung cancers, mesothelioma is not caused by smoking, according to the National Cancer Institute; the Institute reports that 80 percent of mesothelioma patients had known asbestos exposure earlier in life. Mesothelioma can kill quickly; on average, doctors give patients six months to a year to live after their diagnosis. With this in mind, LegalView.com continues to provide factual information, news and links to more information for mesothelioma patients and their families through its mesothelioma and asbestos internet portal.
LegalView.com strives to bring its readers complete, up-to-date information on legal issues that affect ordinary Americans. In addition to the mesothelioma resources, LegalView.com offers comprehensive sites with information concerning brain injury litigation, auto accident lawsuits, diabetes drug Avandia attorneys and peanut butter recall lawyers. These are in addition to general resources LegalView.com maintains on possible unsafe drugs, medical malpractice cases, and defective consumer products and foods. All of these sites, and others at LegalView.com, combine easy-to-understand information facts with the latest news, government information, jury verdicts and settlements, as well as links to more information specific to each legal issue. And for those who are ready to seek out a mesothelioma attorney or other type of experienced lawyer can find one in their areas using LegalView.com's free attorney search service.
LegalView.com is a free public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez Hodes; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's respected sponsoring law firms and to get in touch with LegalView.com attorneys, visit LegalView.com at http://www.legalview.com/.
Press Contact: Alan Haburchak
Company Name: LegalView.com
Wednesday, July 04, 2007
Avandia Information Portal
LegalView.com is pleased to continue bringing its readers important news about Avandia in the aftermath of a recent lawsuit filed by the family of an Avandia patient. LegalView.com also has an extensive collection of resources related to Avandia and other important, relevant legal issues.
Denver, CO (PRWEB) July 4, 2007 -- In the wake of one of the nation's first lawsuits related to diabetes drug Avandia (filed in US District Court for the Eastern District of Texas, Case No. 207CV254), LegalView.com is pleased to remind readers that a complete -- and completely free -- collection of news and information on the drug is available 24 hours a day at avandia.legalview.com.
Avandia is a medication prescribed to control Type 2 diabetes. It came under fire this spring when the New England Journal of Medicine published a study showing that using the drug increased patients' risk of heart attacks by up to an alarming 43 percent. The study also showed that the subjects' risk of death from a cardiac incident was increased by up to 64 percent. In response, the U.S. Food and Drug Administration (FDA) has required manufacturer GlaxoSmithKline to place a "black box" warning on the drug's label. This represents the most serious warning that the FDA can require. As the web's most complete resource for the legal issues that affect Americans, LegalView.com is following the issue closely at its Avandia side effects information portal and related Avandia blog.
While an increased risk of heart attack represents a serious danger to the sufferer of any illness, it is especially devastating for diabetes patients, who already run an increased risk of heart disease. According to the American Diabetes Association (ADA), heart disease or stroke (which has its roots in vascular problems) will be the cause of death for two out of three diabetics, statistically speaking. Visitors looking for this and other factual information on the drug can find it at the Avandia blog, which tracks news and research information as it appears. A recent post discusses the Avandia lawsuit filed in late June in U.S. District Court for the Eastern District of Texas (Case No. 207CV254), by the family of Larry Alan Stafford, who died May 21, 2007 of a heart attack at age 60 -- and had been taking a drug that contained Avandia as one of it components. From there, visitors can move to LegalView.com's free Avandia portal, intended as a complete resource for Avandia patients and their loved ones. The portal collects LegalView.com's original articles on Avandia, news feeds and government announcements on the drug, a glossary of scientific terms related to Avandia, and legal information for concerned patients. In addition, visitors who may want information on finding their own Avandia attorney can take advantage of LegalView.com's attorney referral service, which is confidential, nationwide and always completely free.
The Avandia portal is just part of LegalView.com's extensive collections of factual information on the web about legal issues relevant to Americans. In fact, LegalView.com has built many portals on hot-button legal issues that include original articles, blogs, news feeds, glossaries of unfamiliar scientific or legal terms, jury verdicts and settlements, encyclopedia entries and much more. Some of these portals discuss issues such as the AMO Complete Moisture Plus recall, with information on the possibly tainted contact lens solution; finding a truck accident lawyer, for those who may need legal advice regarding a truck accident; or resources for contacting traumatic brain injury attorneys, who can help obtain compensation for brain-damaged and sometimes permanently disabled individuals. These information portals exist in addition to LegalView.com's wide collection of fast facts and original articles on other important legal topics such as unsafe drugs, defective consumer products, occupational chemical exposure, and recalled or tainted foods. Those who are ready to seek an attorney for these or any other issue can use LegalView.com's free, nationwide attorney referral search to help them find an attorney in their area.
LegalView.com is a free public service put together by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of distinguished law firms from around the United States: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphhreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on LegalView.com's distinguised law firm sponsors and their accomplishments, or to get in touch with LegalView.com's accomplished member attorneys, visit LegalView.com at www.legalview.com.
Press Contact: Alan Haburchak
Company Name: LegalView.com
Tuesday, July 03, 2007
Magazine Features Mesothelioma Lawyers
The "Best Lawyers" list is the "gold standard of reliability and integrity in lawyer ratings."
New York, NY (PRWEB) July 2, 2007 -- The July 2, 2007, issue of New York Magazine features New York mesothelioma lawyers Stanley J. Levy, Robert I. Komitor, and Jerome H. Block on its list of "New York Area's Best Lawyers."
The list published by New York Magazine comprises New York area lawyers who are also listed in the 2007 edition of Best Lawyers in America. According to the magazine, the "Best Lawyers" list is the "gold standard of reliability and integrity in lawyer ratings." Lawyers are selected through an "exhaustive survey" in which lawyers "confidentially evaluate their professional peers". The 2007 edition of Best Lawyers "is based upon more than 2 million evaluations of lawyers by other lawyers."
Messrs. Levy, Komitor and Block all practice with the nationally recognized mesothelioma cancer law firm of Levy Phillips & Konigsberg LLP. The selection of these three mesothelioma lawyers - all born in different generations -- reflects the long history of success the firm has had in asbestos and mesothelioma lawsuits and the valuable role of mentoring in the law firm's ability to reproduce top lawyers generation upon generation.
Mr. Levy has been a pioneer in the effort to obtain compensation for asbestos and mesothelioma victims, filing some of the earliest asbestos lawsuit cases in the 1970s. Mr. Levy litigated many of the first groundbreaking asbestos and mesothelioma lawsuits that established the knowledge of the dangers of asbestos that were known within the asbestos industry, but kept from workers. Mr. Levy's trail-blazing work has paved the way for many thousands of victims of asbestos and mesothelioma to obtain financial compensation nationwide. Born and raised in Brooklyn, Mr. Levy graduated Columbia Law School in 1959 and served for four years as Assistant Attorney General for the State of New York.
Mr. Komitor, who was mentored by Mr. Levy, has become one of the most formidable cancer and mesothelioma lawyers in the nation. Mr. Komitor, the head of the firm's New York Mesothelioma practice, has won many multi-million dollar jury verdicts in asbestos and mesothelioma lawsuits including several verdicts in excess of $10 million dollars. Mr. Komitor's jury verdicts include a $19.5 million dollar jury verdict -- the largest jury verdict ever handed down against a manufacturer of insulated cable. Mr. Komitor grew up on Long Island, and is a 1980 graduate from Hofstra School of Law and teaches jury trial skills to law students as part of the NITA (National Institute of Trial Advocacy) program. Mr. Komitor is a frequent lecturer on topics relating to mass tort litigation, particularly mesothelioma and asbestos.
Mr. Block, at the age of 35, is among the youngest lawyers ever selected to the Best Lawyers List. After graduating law school in 1997 and clerking for a United States District Court Judge, Mr. Block was mentored into a prominent trial lawyer by Messrs. Levy and Komitor, as well as the other accomplished partners at Levy Phillips & Konigsberg. While developing a specialty in mesothelioma cancer law, Mr. Block has become nationally known for his jury verdicts in mesothelioma and lung cancer cases. Mr. Block's jury verdicts include a $22 million verdict on behalf of two New York mesothelioma victims, as well as the first ever asbestos jury verdicts against the welding industry.
To speak to mesothelioma lawyers Levy, Komitor or Block, you may call 212-605-6200 or 1.800.MESO.LAW. You may also visit New York and New Jersey mesothelioma information ranging from clinical trials and treatments to developments in asbestos litigation and mesothelioma cancer law.
Press Contact: Jay Berkowitz
Company Name: CEPAC Phone: (561) 716-1334
Return to Mesothelioma Search Blog Home Page mesothelioma